Analysis of Oxygenation in Chronic Thromboembolic Pulmonary Hypertension Using Dead Space Ratio and Intrapulmonary Shunt Ratio.
Adult
Aged
Angioplasty, Balloon
/ methods
Chronic Disease
Female
Hemodynamics
/ physiology
Hospitals, University
Humans
Hypertension, Pulmonary
/ complications
Japan
Male
Middle Aged
Oxygen Inhalation Therapy
/ methods
Prognosis
Pulmonary Circulation
/ physiology
Pulmonary Embolism
/ complications
Pyrazoles
/ therapeutic use
Pyrimidines
/ therapeutic use
Respiratory Dead Space
/ drug effects
Respiratory Function Tests
Retrospective Studies
Risk Assessment
Severity of Illness Index
Statistics, Nonparametric
Survival Rate
Treatment Outcome
Oxygenation
Pulmonary embolism
Ventilation-perfusion mismatch
Journal
International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240
Informations de publication
Date de publication:
27 Sep 2019
27 Sep 2019
Historique:
pubmed:
6
9
2019
medline:
12
10
2019
entrez:
6
9
2019
Statut:
ppublish
Résumé
Current therapeutic methods for chronic thromboembolic pulmonary hypertension (CTEPH) can improve hemodynamic status and are expected to improve prognoses. However, some patients experience dyspnea during effort and continue supplemental oxygenation despite their hemodynamic status being fully improved. Considering the pathogenesis of CTEPH, the dead space and intrapulmonary shunt are assumed to be responsible for hypoxia in CTEPH, but their contributions are unclear. It is also unclear whether they are improved after treatment. The aim of this study was to investigate the implications of the dead space ratio (DSR) and the intrapulmonary shunt ratio (ISR) for hypoxia in CTEPH and treatment for CTEPH.We retrospectively measured the DSR and ISR of 23 consecutive patients with CTEPH. For 11 of these 23 (10 were treated by balloon pulmonary angioplasty, one with riociguat), we also measured these parameters before and after CTEPH treatments. Overall, the DSR and ISR were abnormally elevated (DSR: 0.63 ± 0.06; ISR: 0.20 ± 0.05). After treatment, mean pulmonary artery pressure was improved (from 40.3 ± 8.1 to 25.5 ± 2.7 mmHg). Although atrial oxygen saturation (SaO
Substances chimiques
Pyrazoles
0
Pyrimidines
0
riociguat
RU3FE2Y4XI
Types de publication
Comparative Study
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM